DUBLIN--(BUSINESS WIRE)--The "2018 Laboratory Market Report" report has been added to ResearchAndMarkets.com's offering.
The 2018 Laboratory Market Report looks at market growth and opportunities across major market segments; including hospital labs, physician office labs, and reference labs.
The report also examines clinical trends including molecular testing, genetic testing, and companion diagnostics.
Key Findings
- The medical laboratory testing market valued at $79 billion in 2017
- Reimbursements cut for 75% of tests on the 2018 Clinical Laboratory Fee Schedule by the Center for Medicare and Medicaid Services
- Genetic testing market grew 150% from 2012-2016
Key Topics Covered
- Executive Summary
- Laboratory Market Overview
- Hospital Lab Market Valued At $47 Billion
- Hospital Lab Test Volumes Increase Five Consecutive Quarters
- POL Market Grows $300 Million In 2017
- POLs Make Up Nearly Half Of U.S. Laboratories
- Drug Testing Spurs Growth In Number Of POLs
- Quest Diagnostics, LabCorp Are Nearly Half Of Reference Lab Market By Revenue
- LabCorp Increases Per Test Revenues
- LabCorp Revenues 13.5% Higher Than Quest In 2017
- Number Of Post-Acute Labs Up 12.5% From 2011 - 2018
- CMS Relies Heavily On Reference Lab Data To Set Rates
- Number Of CLFS Codes Up 18.4% From 2010
- 75% Of Tests On CLFS To Receive Medicare Reimbursement Cuts Under PAMA
- 20 Largest Payment Increases Under PAMA
- 20 Largest Payment Decreases Under PAMA
- Labs Work To Support Value Based Care Models
- Medicare Spending On Lab Testing Down $200M From 2015-2016
- Medicare Spending By Test
- Drug, Molecular Pathology Testing Have Largest Medicare Spending Decreases
- Payment, Coding May Differ Between Test Categories
- POLs Most Vulnerable To Changes In Medicare Reimbursement
- Lab Tech Investment Benefits Hospitals
- Lab Work Most Helpful Aspect Of EHR
- Companion Diagnostics Compliment Pharmaceutical Therapy
- Precision Medicine Market Projected To Exceed $2 Billion By 2022
- Molecular Diagnostics Offer Early Detection
- Syndromic Panel Testing: Multiple Diagnoses In One Test
- Syndromic Panels May Lower Testing Costs
- Majority Of Genetic Tests Are Single-Gene
- Rapid Growth In Number Of Genetic Tests
- Genetic Testing Could Reduce Treatment Costs
- Genomic Testing Costs Rapidly Decline
- Top 25 Tests Total 63% Of Medicare Lab Spend
- Lab Supplies Purchased Through Distribution
- Price Transparency Has No Impact On Clinician Test Ordering
- GHX Market Breakdown Of Clinical Laboratory-Related Product Categories Sold Through Distribution
- GHX Lists Clinical Laboratory Products Sold Through Distribution
- Definitions
For more information about this report visit https://www.researchandmarkets.com/research/5qg7w2/2018_laboratory?w=4
